Transcriptional silencing of the mitochondrial gene NADH dehydrogenase 6 (MT-ND6) results from hypermethylation of its promoter and exhibits a robust correlation with the severity of MASLD (9). This evidence concerns the gene MT-ND6 and metabolic dysfunction-associated steatotic liver disease.